Sign In

​Patents

Zero-order sustained release delivery system for carbamazepine derivatives. U.S. Pat. No. 6,296,873.
 
Anti-fungal compositions with prolonged activity. U.S. Pat. No. 6,197,305.
 
Sustained release formulation of carbamazepine. U.S. Pat. No. 6,162,466.
 
Synergistic herbal extracts. U.S. Pat. No. 6,027,716.
 
Oral antifungal preventative, and method of use. U.S. Pat. No. 5,989,522.
 
Zero-order sustained release matrix tablet formulation of carbamazepine. U.S. Pat. No. 5,980,942.
 
Effervescent granules. U.S. Pat. No. 5,948,439.
 
Local oral herbal slow release tablets. U.S. Pat. No. 5,942,244.
 
Sustained-release pharmaceutical system for the delivery of antioxidants. U.S. Pat. No. 5,897,879.
 
Dental composition for hypersensitive teeth. U.S. Pat. No. 5,849,266.
 
Liquid polymer composition, and method of use. U.S. Pat. No. 5,648,399.
 
Liquid polymer composition, and method of use. U.S. Pat. No. 5,639,795.
 
Liquid polymer composition, and method of use. U.S. Pat. No.5,438,076.
 
Dental composition for hypersensitive teeth. U.S. Pat. No. 5,403,577.
 
Dental varnish composition, and method of use. U.S. Pat. No. 5,330,746.
 
Liquid polymer composition, and method of use. U.S. Pat. No. 5,160,737.
 
Dental composition for hypersensitive teeth. U.S. Pat. No. 5,139,768.
 
Oral antifungal preventative, and method of use. U.S. Pat. No. 5,116,603.
 
Sustained-release pharmaceutical compositions. U.S. Pat. No. 5,023,082.
 
Compositions for the sustained-release of chlorhexidine. U.S. Pat. No. 5,002,769.
 
Novel controlled release dosage form of valproic acid. U.S. Pat. No. 4,913,906.
 
Sustained release tablets of theophylline. U.S. Pat. No. 4,795,645.
×